Actinium Pharmaceuticals, Inc. (ATNM) stock
ATNMNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 10/3079% below fair value
$1.64+0.05 (+3.14%)
Close on Nov 13, 2026Market cap $51.56MP/E 4.6Yield –
Actinium Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Actinium Pharmaceuticals's enterprise value was $13.52M on Nov 11, 2026, against -$10.34M a year earlier. Over the last 5 years it ranged from -$42.79M to $220.03M, with a median of $36.71M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $13.52M | – |
| 2025 | Dec 31, 2025 | -$10.96M | – |
| 2024 | Dec 31, 2024 | -$39.68M | -170.9% |
| 2023 | Dec 29, 2023 | $55.97M | -64.1% |
| 2022 | Dec 30, 2022 | $156.00M | +212.4% |
| 2021 | Dec 31, 2021 | $49.93M | -12.9% |
| 2020 | Dec 31, 2020 | $57.30M | +170.2% |
| 2019 | Dec 31, 2019 | $21.21M | -24.1% |
| 2018 | Dec 31, 2018 | $27.95M | -14.2% |
| 2017 | Dec 29, 2017 | $32.57M | +24.0% |
| 2016 | Dec 30, 2016 | $26.25M | -76.3% |
| 2015 | Dec 31, 2015 | $110.63M | -32.0% |
| 2014 | Dec 31, 2014 | $162.71M | +20.2% |
| 2013 | Dec 31, 2013 | $135.35M | – |
| 2012 | Dec 31, 2012 | -$1.37M | – |
See a number that looks wrong?